Christine H. Chung

27.9k total citations · 8 hit papers
255 papers, 15.6k citations indexed

About

Christine H. Chung is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Christine H. Chung has authored 255 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 94 papers in Pulmonary and Respiratory Medicine and 93 papers in Otorhinolaryngology. Recurrent topics in Christine H. Chung's work include Head and Neck Cancer Studies (92 papers), Lung Cancer Treatments and Mutations (71 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Christine H. Chung is often cited by papers focused on Head and Neck Cancer Studies (92 papers), Lung Cancer Treatments and Mutations (71 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Christine H. Chung collaborates with scholars based in United States, Canada and Japan. Christine H. Chung's co-authors include Maura L. Gillison, Richard C. Jordan, William H. Westra, Jonathan Harris, Kevin P. Redmond, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Harold Kim, Randal S. Weber and K. Kian Ang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Christine H. Chung

247 papers receiving 15.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

2010 4.8k citations William H. Westra, Christine H. Chung et al. profile →
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

2008 1.1k citations Christine H. Chung, Quynh‐Thu Le et al. profile →
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

2004 500 citations Christine H. Chung, Joel S. Parker et al. profile →
Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas

2006 448 citations Christine H. Chung, Kim Ely et al. Journal of Clinical Oncology profile →
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer

2012 359 citations Maura L. Gillison, Richard C. Jordan et al. Journal of Clinical Oncology profile →
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

2014 330 citations William H. Westra, Christine H. Chung et al. Journal of Clinical Oncology profile →
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

2017 317 citations Shanthi Marur, Shuli Li et al. Journal of Clinical Oncology profile →
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma

2014 289 citations Christine H. Chung, Christina S. Kong et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine H. Chung United States	52	7.2k	5.6k	4.7k	4.5k	3.6k	255	15.6k
David Raben United States	48	5.2k 0.7×	6.8k 1.2×	4.4k 0.9×	3.7k 0.8×	5.6k 1.5×	236	15.2k
Ruud H. Brakenhoff Netherlands	59	5.4k 0.7×	6.0k 1.1×	6.2k 1.3×	2.9k 0.7×	2.4k 0.7×	242	15.7k
Ezra E.W. Cohen United States	67	4.7k 0.6×	8.5k 1.5×	4.7k 1.0×	3.2k 0.7×	5.6k 1.5×	421	16.9k
Barbara Burtness United States	56	5.0k 0.7×	8.5k 1.5×	4.4k 0.9×	3.7k 0.8×	5.0k 1.4×	363	16.0k
Roger B. Cohen United States	56	3.9k 0.5×	9.2k 1.6×	5.4k 1.2×	3.4k 0.8×	5.9k 1.6×	328	17.5k
Wayne M. Koch United States	72	8.8k 1.2×	7.5k 1.3×	7.4k 1.6×	6.0k 1.3×	2.8k 0.8×	259	20.9k
Paul M. Harari United States	60	5.9k 0.8×	8.6k 1.5×	4.7k 1.0×	4.0k 0.9×	7.2k 2.0×	303	18.1k
Ying Sun China	60	6.7k 0.9×	5.4k 0.9×	3.6k 0.8×	4.1k 0.9×	3.7k 1.0×	404	15.0k
Dora L.�W. Kwong Hong Kong	53	4.1k 0.6×	3.4k 0.6×	3.3k 0.7×	3.5k 0.8×	3.0k 0.8×	219	11.1k
Luc G.T. Morris United States	57	2.0k 0.3×	4.5k 0.8×	3.0k 0.6×	3.6k 0.8×	2.2k 0.6×	221	12.1k

Countries citing papers authored by Christine H. Chung

Since Specialization

Citations

This map shows the geographic impact of Christine H. Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine H. Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine H. Chung more than expected).

Fields of papers citing papers by Christine H. Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine H. Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine H. Chung. The network helps show where Christine H. Chung may publish in the future.

Co-authorship network of co-authors of Christine H. Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Christine H. Chung. A scholar is included among the top collaborators of Christine H. Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine H. Chung. Christine H. Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gore, L. Robert, Robbert J.C. Slebos, Bradley Sirak, et al.. (2024). A cross-sectional study of the association of dental health factors with progression and all-cause mortality in men diagnosed with HPV-associated oropharyngeal cancer. BMC Oral Health. 24(1). 433–433. 1 indexed citations

Sun, Lova, Jérôme Fayette, Sébastien Salas, et al.. (2024). Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C.. Journal of Clinical Oncology. 42(16_suppl). 6012–6012. 7 indexed citations

Reece, Andrew, et al.. (2023). The CANDOR corpus: Insights from a large multimodal dataset of naturalistic conversation. Science Advances. 9(13). eadf3197–eadf3197. 18 indexed citations

Chaudhary, Ritu, Robbert J.C. Slebos, Feifei Song, et al.. (2023). EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. Cancer Research Communications. 3(5). 896–907. 8 indexed citations

Oswald, Laura B., Naomi C. Brownstein, Junmin Whiting, et al.. (2022). Smoking Is Related to Worse Cancer-related Symptom Burden. The Oncologist. 27(2). e176–e184. 8 indexed citations

Yu, Xiaoqing, Y. Ann Chen, José R. Conejo-García, Christine H. Chung, & Xuefeng Wang. (2019). Estimation of immune cell content in tumor using single-cell RNA-seq reference data. BMC Cancer. 19(1). 715–715. 28 indexed citations

Li, Qian, Xiaoqing Yu, Ritu Chaudhary, et al.. (2019). lncDIFF: a novel quasi-likelihood method for differential expression analysis of non-coding RNA. BMC Genomics. 20(1). 539–539. 8 indexed citations

Valderrábano, Pablo, Laila Khazai, Zachary Thompson, et al.. (2017). Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach. Thyroid. 27(10). 1277–1284. 28 indexed citations

Ozawa, Hiroyuki, Evgeny Izumchenko, Eugene Makarev, et al.. (2017). SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. Clinical Cancer Research. 23(17). 5162–5175. 57 indexed citations

10.

Marur, Shanthi, Shuli Li, Anthony J. Cmelak, et al.. (2017). E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 35(5). 490–497. 317 indexed citations breakdown →

11.

Zumsteg, Zachary S., Natasha Morse, Gaorav P. Gupta, et al.. (2015). Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations. Clinical Cancer Research. 22(8). 2009–2019. 68 indexed citations

12.

Rettig, Eleni M., Christine H. Chung, Justin A. Bishop, et al.. (2015). Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. Cancer Prevention Research. 8(4). 287–295. 43 indexed citations

13.

Bedi, Atul, Xiaofei Chang, Kimberly Noonan, et al.. (2012). Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy. Molecular Cancer Therapeutics. 11(11). 2429–2439. 59 indexed citations

14.

Hayes, D. Neil, Tawee Tanvetyanon, Monika K. Krzyzanowska, et al.. (2012). Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements. Clinical Cancer Research. 18(7). 2056–2065. 120 indexed citations

15.

Slebos, Robbert J.C., Nico Jehmlich, Brandee Brown, et al.. (2012). Proteomic analysis of oropharyngeal carcinomas reveals novel HPV‐associated biological pathways. International Journal of Cancer. 132(3). 568–579. 44 indexed citations

16.

Wang, Jianbo, Kaihua Zhang, Dorota Grabowska, et al.. (2011). Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma. Molecular Cancer Research. 9(12). 1686–1695. 52 indexed citations

17.

Chung, Christine H., Erin H. Seeley, Heinrich Röder, et al.. (2010). Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. 19(2). 358–365. 51 indexed citations

18.

Cohen, Ezra E.W., Hongyan Zhu, Mark W. Lingen, et al.. (2008). A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle. Cancer Research. 69(1). 65–74. 67 indexed citations

19.

Chung, Christine H., Joel S. Parker, Kim Ely, et al.. (2006). Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma. Cancer Research. 66(16). 8210–8218. 197 indexed citations

20.

Slebos, Robbert J.C., Yajun Yi, Kim Ely, et al.. (2006). Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 12(3). 701–709. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact